Once again, Química Clínica Aplicada (QCA) has sponsored the runner-up research project grant for a startup group, endowed with €1,500. This initiative reaffirms our commitment to research and innovation in healthcare.

The project led by Mireia Adell Lleixà has proven to be an exceptional initiative that promotes excellence and high-quality medical education. Additionally, the Doctor Ferran Foundation recognized QCA for its dedication to biomedical research.

We are extremely pleased to announce that Química Clínica Aplicada S.A. has renewed its collaboration agreement with Fundació Doctor Ferran. This renewal strengthens our joint commitment to innovation and research in the health field, further solidifying our partnership for scientific advancement.

A special moment was the awarding of the second-best project grant, a 1500 € runner-up prize sponsored by Química Clínica Aplicada, S.A., to the project "Ordering Heart Failure. Implementation of Lung Ultrasound in the Follow-up of Heart Failure Patients from Primary Care. IC-REPTE Study".

Once again, Química Clínica Aplicada S.A. is honored to sponsor the research grants of the Dr. Ferran Foundation. This year, the foundation will announce the winners at a public event on May 19th, 2022, highlighting QCA's ongoing commitment to biomedical research and scientific development in the Terres de l’Ebre.

This year, the Dr. Ferran runner-up grant for an emerging group, endowed with 1500€ and sponsored by Química Clínica Aplicada S.A., was awarded to the project "Experiences of Newly Joined Professionals at the Intensive Care Unit of Tortosa Verge de la Cinta Hospital During the Covid-19 Pandemic: A Dual Perspective".

Química Clínica Aplicada is pleased to announce that the winner of this year’s emerging group grant is the project titled. This initiative represents a significant advancement in the study of bacterial resistance, a crucially important topic in the field of global public health.